Geneos Wealth Management’s ProShares Ultra Health Care RXL Stock Holding History

Geneos Wealth Management’s Portfolio RXL Stock Details RXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-138,384	Closed	-$7.74M	–	2945
2021 Q4	$7.74M	Buy	+138,384	New	+$7.01M	0.29%	70
2020 Q1	–	Sell	-712	Closed	-$22K	–	2586
2019 Q4	$22K	Hold	712	–	–	﹤0.01%	1642
2019 Q3	$17K	Sell	712 -1,056	-60%	-$26.8K	﹤0.01%	1686
2019 Q2	$46K	Sell	1,768 -194,660	-99%	-$4.83M	﹤0.01%	1233
2019 Q1	$5.13M	Buy	+196,428	New	+$4.95M	0.34%	74
2017 Q4	–	Sell	-92,748	Closed	-$1.98M	–	2209
2017 Q3	$1.98M	Buy	92,748 +30,588	+49%	+$627K	0.2%	125
2017 Q2	$1.24M	Buy	+62,160	New	+$1.15M	0.13%	158

Other funds holding RXL

IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return

OMC

Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

IAN

Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

PFA

Plotkin Financial Advisors Chevy Chase, Maryland $199M AUM 19.26% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Geneos Wealth Management's RXL Position: Q1 2022 in Review

Geneos Wealth Management sold out of ProShares Ultra Health Care (RXL) in Q1 2022, closing a stake of 138,384 shares — an estimated $7.74M sold.

Geneos Wealth Management first reported a position in RXL in Q2 2017 and held it in 7 quarters. The position peaked at $7.74M in Q4 2021. 22 funds tracked by Wall St. Rank hold RXL as of Q1 2022.

Geneos Wealth Management reported no remaining ProShares Ultra Health Care position as of Q1 2022 after selling out during the quarter.
Geneos Wealth Management sold 138,384 ProShares Ultra Health Care shares in Q1 2022, an estimated $7.74M.
Geneos Wealth Management first reported a position in ProShares Ultra Health Care in Q2 2017 and held it in 7 quarters.
Geneos Wealth Management's ProShares Ultra Health Care position peaked at $7.74M in Q4 2021.
22 funds tracked by Wall St. Rank held ProShares Ultra Health Care as of Q1 2022.

Based on Geneos Wealth Management's 13F filing for Q1 2022, filed 16 May 2022.